Assessing sexual function and coping in cervical cancer patients
Sexual Function, Coping and Dyadic Coping in Cervical Cancer Patients: a Comparison Between Surgery and Radiotherapy Plus Chemotherapy
This study looks at how cervical cancer treatments affect sexual function, coping, and emotional well-being in patients to see what changes happen over six months.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 154 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | Female |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Roma, RM) |
| Trial ID | NCT06124040 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate sexual function, coping mechanisms, emotional distress, and quality of life in patients with cervical cancer undergoing either surgical treatment or radiotherapy plus chemotherapy. It will compare these two groups over a six-month period to identify changes in these variables. The study seeks to address the lack of definitive recommendations in existing literature due to conflicting results and poor quality of previous studies. By understanding the psychological and physical impacts of treatment, the findings will inform psycho-educational interventions for patients.
Who should consider this trial
Good fit: Ideal candidates are women aged 18 to 65 who are undergoing non-conservative surgery or radiotherapy plus chemotherapy for cervical cancer.
Not a fit: Patients over 65 years old or those with pre-existing psychopathological disturbances may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved psychological support and interventions for cervical cancer patients, enhancing their sexual health and overall quality of life.
How similar studies have performed: While there is limited consensus in existing literature, this study aims to fill a gap in understanding sexual function and coping in cervical cancer, making it a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients' age ≥ 18 years * Patients undergoing non-conservative surgery or radiotherapy plus chemotherapy * Patients able to understand and sign informed consent Exclusion Criteria: * Patients' age \> 65 years * Patients with inability to express informed consent * Patients denying informed consent * Patients with psychopathological disturbances preexisting to the cancer diagnosis * Patients affected by severe language deficits
Where this trial is running
Roma, RM
- Fondazione Policlinico Agostino Gemelli IRCCS — Roma, Rm, Italy (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.